Clincosm LogoSign in Get a demo

B-cell Lymphoma

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

Active, not recruiting
  • B-Cell Lymphoma
  • Non-Hodgkin Lymphoma
  • Birmingham, Alabama
  • +23 more
Dec 2, 2022

B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

Recruiting
  • B-cell Malignancy
  • +3 more
  • CTX110
  • Los Angeles, California
  • +27 more
May 6, 2022

Chronic Lymphocytic Leukemia, B-Cell Lymphoma Trial in United States (DTRMWXHS-12, DTRM-505, DTRM-555)

Completed
  • Chronic Lymphocytic Leukemia
  • B-Cell Lymphoma
  • Phoenix, Arizona
  • +5 more
Nov 24, 2020

Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

Completed
Has Results
  • Relapsed or Refractory Lymphoproliferative Malignancies
  • +4 more
  • Pralatrexate Injection
  • +3 more
  • Los Angeles, California
  • +14 more
Dec 27, 2019

B-Cell Lymphoma Trial in Worldwide (inotuzumab ozogamicin, Rituximab)

Completed
Has Results
  • B-Cell Lymphoma
  • Birmingham, Alabama
  • +37 more
Feb 6, 2018

B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Philadelphia (Bexxar)

Completed
  • B-cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center, University of Pennsylvania
Aug 15, 2016